isoproterenol and bis(1,4)-diphosphoinositol tetrakisphosphate

isoproterenol has been researched along with bis(1,4)-diphosphoinositol tetrakisphosphate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Safrany, ST; Shears, SB	1

Other Studies

1 other study(ies) available for isoproterenol and bis(1,4)-diphosphoinositol tetrakisphosphate

Article	Year
Turnover of bis-diphosphoinositol tetrakisphosphate in a smooth muscle cell line is regulated by beta2-adrenergic receptors through a cAMP-mediated, A-kinase-independent mechanism. The EMBO journal, 1998, Mar-16, Volume: 17, Issue:6 Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Bradykinin; Cell Line; Cricetinae; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Inositol Phosphates; Isoproterenol; Male; Mesocricetus; Muscle, Smooth; Phosphodiesterase Inhibitors; Phosphorylation; Receptors, Adrenergic, beta-2; Sodium Fluoride; Type C Phospholipases; Vas Deferens	1998

Article

Year

Turnover of bis-diphosphoinositol tetrakisphosphate in a smooth muscle cell line is regulated by beta2-adrenergic receptors through a cAMP-mediated, A-kinase-independent mechanism.

The EMBO journal, 1998, Mar-16, Volume: 17, Issue:6

Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Bradykinin; Cell Line; Cricetinae; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Inositol Phosphates; Isoproterenol; Male; Mesocricetus; Muscle, Smooth; Phosphodiesterase Inhibitors; Phosphorylation; Receptors, Adrenergic, beta-2; Sodium Fluoride; Type C Phospholipases; Vas Deferens

1998